UNIVERSITY OF CALIFORNIA, DAVIS

UNIVERSITY OF CALIFORNIA, DAVIS logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1905-01-01
Employees
10K
Market Cap
-
Website
http://www.ucdavis.edu

Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-03-18
Last Posted Date
2013-04-10
Lead Sponsor
University of California, Davis
Target Recruit Count
8
Registration Number
NCT00864032
Locations
🇺🇸

University of california, Davis Medical Center, Sacramento, California, United States

Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-03-18
Last Posted Date
2017-03-27
Lead Sponsor
University of California, Davis
Target Recruit Count
59
Registration Number
NCT00864396
Locations
🇺🇸

University of California Davis Medical Center, Sacramento, California, United States

Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer

First Posted Date
2009-03-10
Last Posted Date
2017-06-21
Lead Sponsor
University of California, Davis
Target Recruit Count
74
Registration Number
NCT00859157
Locations
🇺🇸

University of California Davis Cancer Center, Sacramento, California, United States

Family Research Study: Metabolism of Fats and Proteins in Specific Ethnic Groups

First Posted Date
2009-03-02
Last Posted Date
2017-05-30
Lead Sponsor
University of California, Davis
Target Recruit Count
325
Registration Number
NCT00853775
Locations
🇺🇸

UC Davis CTSC Clinical Research Center (CCRC) at Veterans Affair Medical Center, Mather, California, United States

Neurohumoral Control of Intestinal Electrical and Mechanical Activity

Completed
Conditions
First Posted Date
2009-02-27
Last Posted Date
2017-05-30
Lead Sponsor
University of California, Davis
Target Recruit Count
45
Registration Number
NCT00852553
Locations
🇺🇸

University of California, Davis Medical Center, Sacramento, California, United States

🇺🇸

University of Nevada School of Medicine, Reno, Nevada, United States

Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma

Phase 2
Active, not recruiting
Conditions
Interventions
First Posted Date
2009-02-20
Last Posted Date
2023-09-01
Lead Sponsor
University of California, Davis
Target Recruit Count
30
Registration Number
NCT00848328
Locations
🇺🇸

University of California Davis Cancer Center, Sacramento, California, United States

Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan

Phase 2
Completed
Conditions
First Posted Date
2009-02-13
Last Posted Date
2017-06-27
Lead Sponsor
University of California, Davis
Target Recruit Count
8
Registration Number
NCT00843947
Locations
🇺🇸

University of CA, Davis Cancer Center, Sacramento, California, United States

Comparison of Video-Based Versus Written Patient Education on Melanoma

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2009-01-22
Last Posted Date
2015-04-22
Lead Sponsor
University of California, Davis
Target Recruit Count
78
Registration Number
NCT00826995
Locations
🇺🇸

University of California Davis Department of Dermatology, Sacramento, California, United States

Comparison Of Video-based Versus Written Patient Education on Sunscreen

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2009-01-22
Last Posted Date
2015-04-16
Lead Sponsor
University of California, Davis
Target Recruit Count
94
Registration Number
NCT00826306
Locations
🇺🇸

University of California Davis Department of Dermatology, Sacramento, California, United States

© Copyright 2024. All Rights Reserved by MedPath